BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 484541)

  • 1. Reduced ferrochelatase activity in fibroblasts from patients with porphyria variegata.
    Viljoen DJ; Cayanis E; Becker DM; Kramer S; Dawson B; Bernstein R
    Am J Hematol; 1979; 6(3):185-90. PubMed ID: 484541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced ferrochelatase activity: a defect common to porphyria variegata and protoporphyria.
    Becker DM; Viljoen JD; Katz J; Kramer S
    Br J Haematol; 1977 Jun; 36(2):171-9. PubMed ID: 871431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protoporphyrin accumulation by mitogen stimulated lymphocytes and protoporphyrinogen oxidase activity in patients with porphyria variegata and erythropoietic protoporphyria: evidence for deficiency of protoporphyrinogen oxidase and ferrochelatase in both diseases.
    Siepker LJ; Kramer S
    Br J Haematol; 1985 May; 60(1):65-74. PubMed ID: 3924091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies in porphyria: functional evidence for a partial deficiency of ferrochelatase activity in mitogen-stimulated lymphocytes from patients with erythropoietic protoporphyria.
    Sassa S; Zalar GL; Poh-Fitzpatrick MB; Anderson KE; Kappas A
    J Clin Invest; 1982 Apr; 69(4):809-15. PubMed ID: 6804493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different characteristics of ferrochelatase in cultured fibroblasts of erythropoietic protoporphyria patients and normal controls.
    Blom C; Klasen EC; Van Steveninck J
    Biochim Biophys Acta; 1990 Jul; 1039(3):339-42. PubMed ID: 2378891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protoporphyrinogen oxidase and ferrochelatase in porphyria variegata.
    Viljoen DJ; Cummins R; Alexopoulos J; Kramer S
    Eur J Clin Invest; 1983 Aug; 13(4):283-7. PubMed ID: 6413214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of deficient heme synthase activity in protoporphyria with cultured skin fibroblasts.
    Bloomer JR
    J Clin Invest; 1980 Feb; 65(2):321-8. PubMed ID: 7356682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zinc chelatase in human lymphocytes: detection of the enzymatic defect in erythropoietic protoporphyria.
    Nunn AV; Norris P; Hawk JL; Cox TM
    Anal Biochem; 1988 Oct; 174(1):146-50. PubMed ID: 3218729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heme synthetase deficiency in human protoporphyria. Demonstration of the defect in liver and cultured skin fibroblasts.
    Bonkowsky HL; Bloomer JR; Ebert PS; Mahoney MJ
    J Clin Invest; 1975 Nov; 56(5):1139-48. PubMed ID: 1184741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An autopsy case of acute porphyria with a decrease of both uroporphyrinogen I synthetase and ferrochelatase activities.
    Yamada M; Kondo M; Tanaka M; Okeda R; Hatakeyama S; Fukui T; Tsukagoshi H
    Acta Neuropathol; 1984; 64(1):6-11. PubMed ID: 6089495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased leukocyte ferrochelatase activity in erythropoietic protoporphyria.
    Kondo M; Ohe M; Mizuguchi M
    J Dermatol; 1989 Apr; 16(2):116-21. PubMed ID: 2778187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme defects in the porphyrias and their relevance to the biochemical abnormalities in these disorders.
    Bloomer JR
    J Invest Dermatol; 1981 Jul; 77(1):102-6. PubMed ID: 7252240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bovine protoporphyria: documentation of autosomal recessive inheritance and comparison with the human disease through measurement of heme synthase activity.
    Bloomer JR; Morton KO; Reuter RJ; Ruth GR
    Am J Hum Genet; 1982 Mar; 34(2):322-30. PubMed ID: 7072720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The enzymatic defect in variegate prophyria. Studies with human cultured skin fibroblasts.
    Brenner DA; Bloomer JR
    N Engl J Med; 1980 Apr; 302(14):765-9. PubMed ID: 7354807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Contribution of Japanese researchers to progress in the field of hematology in the last 100 years: Porphyria/congenital heme synthetase deficiency].
    Sassa S
    Nihon Naika Gakkai Zasshi; 2002 Jul; 91(7):2029-31. PubMed ID: 12187670
    [No Abstract]   [Full Text] [Related]  

  • 16. Enzyme defects in hereditary porphyria.
    Civin WH; Epstein E
    Ann Clin Lab Sci; 1980; 10(5):395-401. PubMed ID: 6999973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietic protoporphyria: evidence that it is due to a variant ferrochelatase.
    Kramer S; Viljoen JD
    Int J Biochem; 1980; 12(5-6):925-30. PubMed ID: 7450150
    [No Abstract]   [Full Text] [Related]  

  • 18. Ferrochelatase deficiency in an infant with anemia and growth delay.
    Carpentieri U; Buck ED; Minguell JJ; Balachandran S; Haggard ME
    Pediatrics; 1979 May; 63(5):757-60. PubMed ID: 440897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of decreased ferrochelatase activity on iron and porphyrin content in mitochondria of mice with porphyria induced by griseofulvin.
    TangerĂ¥s A
    Biochim Biophys Acta; 1986 Jun; 882(1):77-84. PubMed ID: 3707999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietic protoporphyria a clinical and molecular study from Lebanon: Ferrochelatase a potential tumor suppressor gene in colon cancer.
    Kadara H; Nemer G; Safi R; Rebeiz N; Daou L; Delbani D; Btadini W; Abbas O; Tofaili M; Bitar F; Kibbi AG; Shimomura Y; Kurban M
    Clin Genet; 2017 Nov; 92(5):495-502. PubMed ID: 28075030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.